City

Los Angeles (1)

Portland (1)

Condition

Stage IB Melanoma (2)

Stage IIA Melanoma (2)

Stage IIB Melanoma (2)

Stage IIC Melanoma (2)

Recurrent Melanoma (1)

Stage IA Melanoma (1)

Stage IIIA Melanoma (1)

Stage IIIB Melanoma (1)

Stage IIIC Melanoma (1)

Overall Status

Completed (1)

Withdrawn (1)

Sign in for free

Phase

phase 2 (1)

phase 3 (1)

Sponsor

Jonsson Comprehensive Cancer Center (1)

National Cancer Institute (NCI) (1)

Collaborator

Genzyme, a Sanofi Company (1)

National Cancer Institute (NCI) (1)

Intervention

laboratory biomarker analysis (2)

gp100:209-217(210m) (1)

hpv 16 e7:12-20 (1)

hypertonic saline (1)

sargramostim (1)

sentinel lymph node biopsy (1)

Study Documents

Intervention Type

biological (2)

other (2)

procedure (1)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (2)

stage ib melanoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Stage IB Melanoma, Stage IIA Melanoma, Stage IIB Melanoma Trial in Los Angeles (biological, procedure, other)

Withdrawn

Stage IB Melanoma
+3 more

sargramostim
+3 more

Los Angeles, California

Jonsson Comprehensive Cancer Center

Jul 23, 2020

Recurrent Melanoma, Stage IA Melanoma, Stage IB Melanoma Trial in Portland (HPV 16 E7:12-20, gp100:209-217(210M), laboratory

Completed

Has Results

Recurrent Melanoma
+8 more

HPV 16 E7:12-20
+2 more

Portland, Oregon

Providence Portland Medical Center

Dec 28, 2016